Carla I. Falkson
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Bone health and treatments
- CAR-T cell therapy research
- Cancer Diagnosis and Treatment
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 73
- Cancer Treatment and Pharmacology 31
- HER2/EGFR in Cancer Research 19
- Bone health and treatments 9
- Cancer Diagnosis and Treatment 8
-
- Breast Cancer Treatment Studies 19
- Co-authors
- Geoffrey FalksonH. C. FalksonRonald H. BlumMichael B. AtkinsAlan S. CoatesJoseph IbrahimJohn M. KirkwoodGraham Cohen
- Journals
- Journal of Clinical Oncology (26 papers)Oncology (9 papers)Investigational New Drugs (5 papers)Annals of Oncology (4 papers)Clinical Breast Cancer (3 papers)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Carla I. Falkson
92 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 117
- Oncology 1.8k
- Cancer Research 797
- Immunology 423
- Pulmonary and Respiratory Medicine 528
- Radiology, Nuclear Medicine and Imaging 316
Countries citing papers authored by Carla I. Falkson
This map shows the geographic impact of Carla I. Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla I. Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla I. Falkson more than expected).
Fields of papers citing papers by Carla I. Falkson
This network shows the impact of papers produced by Carla I. Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla I. Falkson. The network helps show where Carla I. Falkson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carla I. Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 17 | |
| 3 | 2020 | 9 | |
| 4 | 2010 | 29 | |
| 5 | 2004 | 39 | |
| 6 | 2000 | 19 | |
| 7 | 1998 | 36 | |
| 8 | 1997 | 16 | |
| 9 | 1996 | 53 | |
| 10 | 1996 | 14 | |
| 11 | 1996 | 21 | |
| 12 | 1996 | 2 | |
| 13 | 1994 | 14 | |
| 14 | 1993 | 10 | |
| 15 | 1992 | 5 | |
| 16 | 1991 | 2 | |
| 17 | 1991 | 1 | |
| 18 | 1990 | 42 | |
| 19 | 1988 | 4 | |
| 20 | 1988 | 8 |
About Carla I. Falkson
Carla I. Falkson is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Dermatology and Pathology and Forensic Medicine, having authored 95 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (31 papers), HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (19 papers), Breast Cancer Treatment Studies (19 papers), Bone health and treatments (9 papers), Cancer Diagnosis and Treatment (8 papers), Melanoma and MAPK Pathways (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (797 citations), Immunology (423 citations), Pulmonary and Respiratory Medicine (528 citations) and Radiology, Nuclear Medicine and Imaging (316 citations). Carla I. Falkson has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Geoffrey Falkson, H. C. Falkson, Ronald H. Blum, Michael B. Atkins, Alan S. Coates, Joseph Ibrahim, John M. Kirkwood, Graham Cohen, Joseph A. Sparano and Huang-Ge Zhang. Their work appears in journals such as Journal of Clinical Oncology, Oncology, Investigational New Drugs, Annals of Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.